World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
33884
World Ranking
10453
National Ranking
1001

Overview

John F.R. Robertson is affiliated with the University of Nottingham in the United Kingdom. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, contributing notably to the areas of Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics, and Surgery.

Their work focuses on several key topics including:

  • Estrogen and related hormone effects
  • Breast Cancer Treatment Studies
  • Advanced Breast Cancer Therapies
  • HER2/EGFR in Cancer Research
  • Global Cancer Incidence and Screening
  • Cancer Treatment and Pharmacology
  • Cancer survivorship and care

Among recent publications, the following papers reflect some of the contributions made:

  • "Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13,864 women in seven randomised trials" (2021), published in The Lancet Oncology
  • "Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial" (2020), published in The Lancet Oncology
  • "ESR1 Mutations and Overall Survival on Fulvestrant versus Exemestane in Advanced Hormone Receptor-Positive Breast Cancer: A Combined Analysis of the Phase III SoFEA and EFECT Trials" (2020), published in Clinical Cancer Research
  • "Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14,324 women in 16 trials" (2023), published in The Lancet
  • "Evidence-based guidelines for managing patients with primary ER+ HER2− breast cancer deferred from surgery due to the COVID-19 pandemic" (2020), published in npj Breast Cancer

Frequently collaborating with other researchers, John F.R. Robertson has co-authored numerous works alongside:

  • Judith M. Bliss
  • Mitch Dowsett
  • Lucy Kilburn
  • Holly Tovey
  • Maggie C.U. Cheang

Their publications have appeared consistently in various scientific venues, with multiple contributions to:

  • Cancer Research
  • European Journal of Surgical Oncology
  • Clinical Cancer Research
  • The Lancet
  • BMJ Open Quality

Best Publications

  • Prognostic markers in triple-negative breast cancer

    Emad A. Rakha;Maysa E. El-Sayed;Andrew R. Green;Andrew H. S. Lee

  • Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study

    J Bonneterre;B Thurlimann;J Robertson;M Krzakowski

  • Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    Bernard Asselain;William Barlow;John Bartlett;Jonas Bergh

  • Fulvestrant, Formerly ICI 182,780, Is as Effective as Anastrozole in Postmenopausal Women With Advanced Breast Cancer Progressing After Prior Endocrine Treatment

    Anthony Howell;John F R Robertson;J Quaresma Albano;A Aschermannova

  • Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

    J. Bergh;K. Pritchard;K. Albain;S. Anderson

  • High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

    Dalia M. Abd El-Rehim;Graham Ball;Sarah E. Pinder;Emad Rakha

  • Expression of luminal and basal cytokeratins in human breast carcinoma

    Dalia M Abd El-Rehim;Sarah E Pinder;Claire E Paish;J Bell

  • Anastrozole Is Superior to Tamoxifen as First-Line Therapy in Hormone Receptor Positive Advanced Breast Carcinoma Results of Two Randomized Trials Designed for Combined Analysis

    Jacques Bonneterre;Aman Buzdar;Jean‐Marc A. Nabholtz;John F. R. Robertson

  • Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT.

    Stephen Chia;William Gradishar;Louis Mauriac;Jose Bines

  • Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial.

    John F.R. Robertson;Igor M. Bondarenko;Ekaterina Trishkina;Mikhail Dvorkin

  • Comparison of fulvestrant versus tamoxifen for the treatment of advanced breast cancer in postmenopausal women previously untreated with endocrine therapy: a multinational, double-blind, randomized trial.

    Anthony Howell;John F R Robertson;Paul Abram;Mikhail R Lichinitser

  • Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer

    Anthony Howell;John Robertson

  • Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

    E A Rakha;T C Putti;D M Abd El-Rehim;C Paish

  • Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women: a prospective combined analysis of two multicenter trials.

    John F.R. Robertson;C. Kent Osborne;Anthony Howell;Stephen E. Jones

  • Biologic and Clinical Characteristics of Breast Cancer With Single Hormone Receptor–Positive Phenotype

    Emad A. Rakha;Maysa E. El-Sayed;Andrew R. Green;E. Claire Paish

  • Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer.

    Emad A Rakha;Richard W G Boyce;Dalia Abd El-Rehim;Thomas Kurien

  • Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer

    Julia Margaret Wendy Gee;J. F. Robertson;E. Gutteridge;I. O. Ellis

  • Activity of Fulvestrant 500 mg Versus Anastrozole 1 mg As First-Line Treatment for Advanced Breast Cancer: Results From the FIRST Study

    John F.R. Robertson;Antonio Llombart-Cussac;Janusz Rolski;David Feltl

  • Ki67 immunostaining in primary breast cancer: pathological and clinical associations.

    N. Bouzubar;K. J. Walker;K. Griffiths;I. O. Ellis

  • Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

    Richard Gray;Rosie Bradley;Jeremy Braybrooke;Zulian Liu

Frequent Co-Authors

Ian O. Ellis
Ian O. Ellis University of Nottingham
Robert Ian Nicholson
Robert Ian Nicholson Cardiff University
Roger W. Blamey
Roger W. Blamey Nottingham City Hospital
Julia Margaret Wendy Gee
Julia Margaret Wendy Gee Cardiff University
Sarah E Pinder
Sarah E Pinder King's College London
Mitch Dowsett
Mitch Dowsett Breast Cancer Research Foundation
Anthony Howell
Anthony Howell University of Manchester
C.W. Elston
C.W. Elston University of Nottingham
Matthew J. Ellis
Matthew J. Ellis Baylor College of Medicine
Andrew Evans
Andrew Evans University of Dundee

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine goes beyond becoming a doctor. The healthcare field in the U.S. offers a variety of related degree options and career pathways, many of which can be pursued online for added flexibility. For those interested in nursing, some nursing schools that don't require teas test can provide a more accessible route into the nursing profession.

If you are more interested in management or organizational roles, consider an online healthcare administration degree. This can open doors to leadership positions in hospitals, clinics, and public health organizations.

RNs looking to advance their careers may benefit from adn to np programs online, which provide flexible bridge programs to help nurses become nurse practitioners faster. Additionally, those passionate about wellness and nutrition can earn an online bs in nutrition to explore roles in dietetics, health coaching, and education.

Exploring these related online degrees can help you tailor a healthcare career that fits your strengths and interests, all while balancing work and study commitments.

Best Scientists Citing John F.R. Robertson

Trending Scientists